GreenBone Ortho


GreenBone Ortho is dedicated to providing innovative, safe, and effective solutions for bone regeneration inspired by nature. Their mission is to develop biomimetic and bioactive bone substitutes, utilizing a proprietary process to transform rattan wood into a biomimetic bone substitute that facilitates bone regeneration. The company emphasizes sustainability and environmental responsibility, aiming to lead in the field of bone healing and regeneration through continuous innovation and scientific research.

Industries

biometrics
biopharma
biotechnology
medical

Nr. of Employees

small (1-50)

GreenBone Ortho

Via Albert Einstein, 8, 48018 Faenza (RA), Italy


Patents

Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them

US-11357886-B2

View Details

Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them

US-11213605-B2

View Details

Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them

US-10688218-B2

View Details

Implants for “load bearing” bone substitutions having hierarchical organized architecture deriving from transformation of vegetal structures

US-9326948-B2

View Details

Products

Biomimetic porous bone graft substitute (cylinders)

Porous apatitic ceramic cylinders intended for implantation into bony voids or gaps in extremities and pelvis; available in defined diameters and lengths.

Biomimetic porous bone graft substitute (blocks and wedges)

Porous apatitic ceramic blocks and wedges intended for anatomical reconstruction and defect augmentation; available in specified width/depth/height or angle configurations.

Biomimetic porous bone graft substitute (granules)

Porous apatitic ceramic granules provided in defined size ranges and quantities for use as graft expander or defect filler.


Services

Design and conduct of first-in-human, multi-centre and post-market clinical investigations to collect safety and performance data for bone graft materials.

Production and distribution of biomimetic porous bone grafts in standardized shapes and sizes intended for implantation into bony voids and gaps in extremities and pelvis.

Expertise Areas

  • Bone regeneration and graft substitutes
  • Ceramic scaffold biomaterials
  • Orthopaedic clinical research and study execution
  • Medical device regulatory compliance (CE, MDR post-market surveillance)
  • Show More (2)

Key Technologies

  • Hydroxyapatite/β‑tricalcium phosphate ceramic formulation
  • Biomorphic conversion of plant-derived templates
  • Hierarchical interconnected porous scaffold fabrication
  • 3D scaffold sizing and shape manufacturing (cylinders, blocks, wedges, granules)
  • Show More (3)

News & Updates

GreenBone and Endocon have formed a strategic partnership to bring GreenBone’s bone substitute to Germany and Austria.

GreenBone will attend the 13th Hull Deformity Planning Course in June 2024.

An update on the OSsIRIS clinical study, highlighting the enrollment of the first UK patient.

GreenBone announced the enrollment of the first patient for their OSsIRIS study at the University Medical Centre in Regensburg, Germany.

GreenBone announced the enrollment of the first patient for their OSsIRIS study at the University Medical Centre in Regensburg, Germany.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.